{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:54:43Z","timestamp":1791309283302,"version":"4.3.1"},"reference-count":84,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Indian Acad Neurol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0972-2327.182302","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T00:48:50Z","timestamp":1471308530000},"page":"175","source":"Crossref","is-referenced-by-count":148,"title":["Understanding migraine: Potential role of neurogenic inflammation"],"prefix":"10.4103","volume":"19","author":[{"given":"Rakesh","family":"Malhotra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0972-2327.182302-1","first-page":"427","volume-title":"The prevalence, impact, and treatment of migraine and severe headaches in the United States: A review of statistics from national surveillance studies","author":"Smitherman","year":"2013","journal-title":"Headache"},{"key":"key-10.4103\/0972-2327.182302-2","unstructured":"Wolff HG. Headache and Other Head Pain. New York: Oxford University Press; 1963."},{"key":"key-10.4103\/0972-2327.182302-3","first-page":"105","volume-title":"The pathophysiology of migraine: Year 2005","author":"Buzzi","year":"2005","journal-title":"J Headache Pain"},{"key":"key-10.4103\/0972-2327.182302-4","first-page":"537","volume-title":"Meningeal afferent signaling and the pathophysiology of migraine","author":"Burgos-Vega","year":"2015","journal-title":"Prog Mol Biol Transl Sci"},{"key":"key-10.4103\/0972-2327.182302-5","first-page":"173","volume-title":"On the origin from the spinal cord of the vaso-dilator fibers of the hind limb, and on the nature of these fibers","author":"Bayliss","year":"1901","journal-title":"J Physiol"},{"key":"key-10.4103\/0972-2327.182302-6","first-page":"103","volume-title":"Antidromic vasodilatation and the migraine mechanism","author":"Geppetti","year":"2012","journal-title":"J Headache Pain"},{"key":"key-10.4103\/0972-2327.182302-7","first-page":"61","volume-title":"Neurogenic vasodilation in rabbit basilar isolated artery: Involvement of calcitonin-gene related peptide","author":"Olivar","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/0972-2327.182302-8","first-page":"23","volume-title":"Calcitonin gene-related peptide is a key neurotransmitter in the neuro-immune axis","author":"Assas","year":"2014","journal-title":"Front Neurosci"},{"key":"key-10.4103\/0972-2327.182302-9","first-page":"332","volume-title":"Calcitonin gene-related peptide activates the K+ channels of vascular smooth muscle cells via adenylate cyclase","author":"Miyoshi","year":"1995","journal-title":"Basic Res Cardiol"},{"key":"key-10.4103\/0972-2327.182302-10","first-page":"2057","volume-title":"Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons","author":"Bellamy","year":"2006","journal-title":"Eur J Neurosci"},{"key":"key-10.4103\/0972-2327.182302-11","first-page":"125","volume-title":"Co-localization of calcitonin gene-related peptide-like immunoreactivity with substance P in cutaneous, vascular and visceral sensory neurons of guinea pigs","author":"Gibbins","year":"1985","journal-title":"Neurosci Lett"},{"key":"key-10.4103\/0972-2327.182302-12","first-page":"117","volume-title":"The assessment of vasoactive properties of CGRP and adrenomedullin in the microvasculature: A study using in vivo and in vitro assays in the mouse","author":"Tam","year":"2004","journal-title":"J Mol Neurosci"},{"key":"key-10.4103\/0972-2327.182302-13","unstructured":"Hunt SP, O'Brien JA, Palmer JA. Role of substance P in nociception, analgesia, and aggression. In: Wood JN, editor. Molecular Basis of Pain Induction. New York: John Wiley & Sons; 2000. p. 209-60."},{"key":"key-10.4103\/0972-2327.182302-14","first-page":"1073","volume-title":"CGRP-receptor antagonists \u2014 a fresh approach to migraine therapy?","author":"Durham","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0972-2327.182302-15","first-page":"649","volume-title":"Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors","author":"van","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"key-10.4103\/0972-2327.182302-16","first-page":"69","volume-title":"Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides","author":"Zagami","year":"1990","journal-title":"Neuropeptides"},{"key":"key-10.4103\/0972-2327.182302-17","first-page":"183","volume-title":"Vasoactive peptide release in the extracerebral circulation of humans during migraine headache","author":"Goadsby","year":"2004","journal-title":"Ann Neurol"},{"key":"key-10.4103\/0972-2327.182302-18","first-page":"551","volume-title":"Receptors and antagonists for substance P and related peptides","author":"Regoli","year":"1994","journal-title":"Pharmacol Rev"},{"key":"key-10.4103\/0972-2327.182302-19","first-page":"303","volume-title":"Contribution to the theory that substance P has a transmitter role in sensitive pathway","author":"Gasporovic","year":"1964","journal-title":"Med Exp Int J Exp Med"},{"key":"key-10.4103\/0972-2327.182302-20","first-page":"302","volume-title":"Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey","author":"Battaglia","year":"1988","journal-title":"J Comp Neurol"},{"key":"key-10.4103\/0972-2327.182302-21","first-page":"721","volume-title":"NMDA-receptor regulation of substance P release from primary afferent nociceptors","author":"Liu","year":"1997","journal-title":"Nature"},{"key":"key-10.4103\/0972-2327.182302-22","first-page":"38","volume-title":"The role of histamine in neurogenic inflammation","author":"Rosa","year":"2013","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/0972-2327.182302-23","first-page":"518","volume-title":"Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat","author":"Williamson","year":"1997","journal-title":"Cephalalgia"},{"key":"key-10.4103\/0972-2327.182302-24","first-page":"613","volume-title":"Neurokinin 1 receptor antagonists \u2014 current prospects","author":"Alvaro","year":"2007","journal-title":"Curr Opin Drug Discov Devel"},{"key":"key-10.4103\/0972-2327.182302-25","first-page":"419","volume-title":"5-HT receptor classification and nomenclature: Towards a harmonization with the human genome","author":"Hoyer","year":"1997","journal-title":"Neuropharmacology"},{"key":"key-10.4103\/0972-2327.182302-26","first-page":"20120537","volume-title":"The serotonergic system in mood disorders and suicidal behaviour","author":"Mann","year":"2013","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"key-10.4103\/0972-2327.182302-27","first-page":"219","volume-title":"Serotonin in migraine: Theories, animal models and emerging therapies","author":"Johnson","year":"1998","journal-title":"Prog Drug Res"},{"key":"key-10.4103\/0972-2327.182302-28","first-page":"9545","volume-title":"Repression of the calcitonin gene-related peptide promoter by 5-HT1 receptor activation","author":"Durham","year":"1997","journal-title":"J Neurosci"},{"key":"key-10.4103\/0972-2327.182302-29","first-page":"202","volume-title":"The antimigraine drug, sumatriptan (GR43175) selectively blocks neurogenic plasma extravasation from blood vessels in dura matter","author":"Buzzi","year":"1990","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/0972-2327.182302-30","first-page":"1043","volume-title":"Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis","author":"Cutrer","year":"1999","journal-title":"Neuropharmacology"},{"key":"key-10.4103\/0972-2327.182302-31","first-page":"73","volume-title":"BF-1\u2014a novel selective 5-HT2B receptor antagonist blocking neurogenic dural plasma protein extravasation in guinea pigs","author":"Schmitz","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/0972-2327.182302-32","first-page":"9324","volume-title":"PDZ-dependent activation of nitric-oxide synthases by the serotonin 2B receptor","author":"Manivet","year":"2000","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0972-2327.182302-33","first-page":"199","volume-title":"Effect of nitric oxide on substance P release from the peripheral endings of primary afferent neurons","author":"Yonehara","year":"1999","journal-title":"Neurosci Lett"},{"key":"key-10.4103\/0972-2327.182302-34","first-page":"1075","volume-title":"RS-127445: A selective, high affinity, orally bioavailable 5-HT2B receptor antagonist","author":"Bonhaus","year":"1999","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/0972-2327.182302-35","first-page":"1","volume-title":"Is the 5-HT(7) receptor involved in the pathogenesis and prophylactic treatment of migraine?","author":"Terr\u00f3n","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/0972-2327.182302-36","first-page":"13","volume-title":"Neurotrophic factors: Important regulators of nociceptive function","author":"Bennett","year":"2001","journal-title":"Neuroscientist"},{"key":"key-10.4103\/0972-2327.182302-37","first-page":"2303","volume-title":"NGF and GDNF differentially regulate TRPV1 expression that contributes to development of inflammatory thermal hyperalgesia","author":"Amaya","year":"2004","journal-title":"Eur J Neurosci"},{"key":"key-10.4103\/0972-2327.182302-38","first-page":"390","volume-title":"Decreased CGRP, but preserved Trk A immunoreactivity in nerve fibers in inflamed human superficial temporal arteries","author":"Saldanha","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0972-2327.182302-39","first-page":"4","volume-title":"Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: Effects on neuronal survival, neurchemial properties and TRVP1-medated neuropeptide secretion","author":"Price","year":"2005","journal-title":"BMC Neurosci"},{"key":"key-10.4103\/0972-2327.182302-40","first-page":"323","volume-title":"Intraplantar injection of nerve growth factor into the rat hind paw: Local edema and effects on thermal nociceptive threshold","author":"Amann","year":"1996","journal-title":"Pain"},{"key":"key-10.4103\/0972-2327.182302-41","first-page":"60","volume-title":"Regeneration effect of human recombinant NGF on capsaicin-lesioned sensory neurons in the adult rat","author":"Schicho","year":"1999","journal-title":"Brain Res"},{"key":"key-10.4103\/0972-2327.182302-42","first-page":"6","volume-title":"Migraine is associated with altered levels of neurotrophins","author":"Martins","year":"2015","journal-title":"Neurosci Lett"},{"key":"key-10.4103\/0972-2327.182302-43","first-page":"577","volume-title":"Endogenous nitric oxide synthesis: Biological functions and pathophysiology","author":"Bredt","year":"1999","journal-title":"Free Radic Res"},{"key":"key-10.4103\/0972-2327.182302-44","first-page":"131","volume-title":"Physiological and pathophysiological roles of nitric oxide in the central nervous system","author":"Szab\u00f3","year":"1996","journal-title":"Brain Res Bull"},{"key":"key-10.4103\/0972-2327.182302-45","first-page":"157","volume-title":"The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache","author":"Olesen","year":"2008","journal-title":"Pharmacol Ther"},{"key":"key-10.4103\/0972-2327.182302-46","first-page":"117","volume-title":"Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation","author":"Johnson","year":"2003","journal-title":"Cephalalgia"},{"key":"key-10.4103\/0972-2327.182302-47","first-page":"136","volume-title":"Nitric oxide synthase, calcitonin gene-related peptide and NK-1 receptor mechanisms are involved in GTN-induced neuronal activation","author":"Ramachandran","year":"2014","journal-title":"Cephalalgia"},{"key":"key-10.4103\/0972-2327.182302-48","first-page":"105","volume-title":"The effect of the nitric oxide synthase inhibitor N-nitro-L-arginine-methyl ester on neuropeptide-induced vasodilation and protein extravasation in human skin","author":"Klede","year":"2003","journal-title":"J Vasc Res"},{"key":"key-10.4103\/0972-2327.182302-49","first-page":"672","volume-title":"Asymmetric dimethylarginine and nitric oxide levels in migraine during the interictal period","author":"Guldiken","year":"2009","journal-title":"J Clin Neurosci"},{"key":"key-10.4103\/0972-2327.182302-50","first-page":"153","volume-title":"Prostaglandin and thromboxane biosynthesis","author":"Smith","year":"1991","journal-title":"Pharmacol Ther"},{"key":"key-10.4103\/0972-2327.182302-51","first-page":"5411","volume-title":"Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3',5'-cyclic monophosphate transduction cascade","author":"Hingtgen","year":"1995","journal-title":"J Neurosci"},{"key":"key-10.4103\/0972-2327.182302-52","first-page":"901","volume-title":"Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro","author":"Ebersberger","year":"1999","journal-title":"Neuroscience"},{"key":"key-10.4103\/0972-2327.182302-53","first-page":"276","volume-title":"Effects of parecoxib on plasma protein extravasation and c-fos expression in the rat","author":"Schuh-Hofer","year":"2006","journal-title":"Headache"},{"key":"key-10.4103\/0972-2327.182302-54","first-page":"16","volume-title":"The 'ABC' of GABA receptors","author":"Bormann","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"key-10.4103\/0972-2327.182302-55","first-page":"516","volume-title":"Cerebrospinal fluid gamma aminobutyric acid levels in migraine","author":"Welch","year":"1975","journal-title":"Br Med J"},{"key":"key-10.4103\/0972-2327.182302-56","first-page":"CD010611","volume-title":"Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0972-2327.182302-57","first-page":"48","volume-title":"Progesterone and allopregnanolone in the central nervous system: Response to injury and implication for neuroprotection","author":"Guennoun","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key-10.4103\/0972-2327.182302-58","first-page":"223","volume-title":"Capsaicin receptor immunoreactivity in the human trigeminal ganglion","author":"Hou","year":"2002","journal-title":"Neurosci Lett"},{"key":"key-10.4103\/0972-2327.182302-59","first-page":"718","volume-title":"Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation","author":"Akerman","year":"2003","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/0972-2327.182302-60","first-page":"671","volume-title":"Intranasal medications for the treatment of migraine and cluster headache","author":"Rapoport","year":"2004","journal-title":"CNS Drugs"},{"key":"key-10.4103\/0972-2327.182302-61","first-page":"160","volume-title":"Complex regional pain syndrome\/reflex sympathetic dystrophy","author":"Jakubowicz","year":"2010","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"key-10.4103\/0972-2327.182302-62","first-page":"251","volume-title":"Facilitated neurogenic inflammation in complex regional pain syndrome","author":"Weber","year":"2001","journal-title":"Pain"},{"key":"key-10.4103\/0972-2327.182302-63","first-page":"163","volume-title":"Facilitated neurogenic inflammation in unaffected limbs of patients with complex regional pain syndrome","author":"Leis","year":"2004","journal-title":"Neurosci Lett"},{"key":"key-10.4103\/0972-2327.182302-64","first-page":"75","volume-title":"A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II","author":"Kingery","year":"2003","journal-title":"Pain"},{"key":"key-10.4103\/0972-2327.182302-65","first-page":"680","volume-title":"Fibromyalgia and related conditions","author":"Clauw","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"key-10.4103\/0972-2327.182302-66","first-page":"259","volume-title":"Peripheral and central sensitization in fibromyalgia: Pathogenetic role","author":"Staud","year":"2002","journal-title":"Curr Pain Headache Rep"},{"key":"key-10.4103\/0972-2327.182302-67","first-page":"2906","volume-title":"Image analysis quantification of substance P immunoreactivity in the trapezius muscle of patients with fibromyalgia and myofacial pain syndrome","author":"De","year":"2000","journal-title":"J Rheumatol"},{"key":"key-10.4103\/0972-2327.182302-68","first-page":"21","volume-title":"Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: New features for diagnosis","author":"Vaeroy","year":"1988","journal-title":"Pain"},{"key":"key-10.4103\/0972-2327.182302-69","doi-asserted-by":"crossref","unstructured":"Corrigan F, Vink R, Turner RJ. Inflammation in acute CNS injury: A focus on the role of substance P. Br J Pharmacol 2015. [Epub ahead of print].","DOI":"10.1111\/bph.13155"},{"key":"key-10.4103\/0972-2327.182302-70","first-page":"359","volume-title":"A randomized clinical trial of efficacy and safety of the topical clonidine and capsaicin in the treatment of painful diabetic neuropathy","author":"Kiani","year":"2015","journal-title":"J Res Med Sci","ISSN":"https:\/\/id.crossref.org\/issn\/1735-1995","issn-type":"print"},{"key":"key-10.4103\/0972-2327.182302-71","first-page":"1104","volume-title":"; BIBN 4096 BS Clinical Proof of Concept Study Group.Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine","author":"Olesen","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0972-2327.182302-72","first-page":"1553","volume-title":"The non-peptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigs","author":"Phebus","year":"1997","journal-title":"Life Sci"},{"key":"key-10.4103\/0972-2327.182302-73","first-page":"407","volume-title":"A placebo-controlled, in-clinic study to explore the preliminary safety and efficacy of intravenous L-758,298 (a prodrug of the NK1 receptor antagonist L-754,030) in the acute treatment of migraine","author":"Norman","year":"1998","journal-title":"Cephalalgia"},{"key":"key-10.4103\/0972-2327.182302-74","first-page":"23","volume-title":"The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular system","author":"Polley","year":"1997","journal-title":"Regul Pept"},{"key":"key-10.4103\/0972-2327.182302-75","first-page":"395","volume-title":"Nitric oxide synthase inhibitors for the treatment of chronic tension-type headache","author":"Ashina","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.4103\/0972-2327.182302-76","first-page":"851","volume-title":"Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370","author":"Shepheard","year":"1999","journal-title":"Cephalalgia"},{"key":"key-10.4103\/0972-2327.182302-77","first-page":"357","volume-title":"Efficacy and tolerability of the neurogenic inflammation inhibitor, 4991W93, in the acute treatment of migraine","author":"Earl","year":"1999","journal-title":"Cephalalgia"},{"key":"key-10.4103\/0972-2327.182302-78","first-page":"727","volume-title":"Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine","author":"Gomez-Mantilla","year":"2001","journal-title":"Cephalalgia"},{"key":"key-10.4103\/0972-2327.182302-79","first-page":"315","volume-title":"Role of endothelin in mediating neurogenic plasma extravasation in rat dura mater","author":"Br\u00e4ndli","year":"1996","journal-title":"Pain"},{"key":"key-10.4103\/0972-2327.182302-80","first-page":"838","volume-title":"Botulinum toxin A in the prophylactic treatment of migraine \u2014 a randomized, double-blind, placebo-controlled study","author":"Evers","year":"2004","journal-title":"Cephalalgia"},{"key":"key-10.4103\/0972-2327.182302-81","first-page":"H2124","volume-title":"Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons","author":"Morris","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key-10.4103\/0972-2327.182302-82","first-page":"76","volume-title":"Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin","author":"Tugnoli","year":"2007","journal-title":"Pain"},{"key":"key-10.4103\/0972-2327.182302-83","first-page":"672","volume-title":"Could statins be useful in the treatment of patients with migraine?","author":"Liberopoulos","year":"2006","journal-title":"Headache"},{"key":"key-10.4103\/0972-2327.182302-84","first-page":"76","volume-title":"Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model","author":"Kim","year":"2007","journal-title":"Eur J Pharmacol"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:30:46Z","timestamp":1786714246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0972-2327.182302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"alternative-id":["182302"],"URL":"https:\/\/doi.org\/10.4103\/0972-2327.182302","relation":{},"ISSN":["0972-2327"],"issn-type":[{"value":"0972-2327","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}